A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer's disease.
Douglas P WightmanIris E JansenJeanne E SavageAlexey A ShadrinShahram BahramiDominic HollandArvid RongveSigrid BørteBendik Slagsvold WinsvoldOle Kristian DrangeAmy E MartinsenAnne Heidi SkogholtCristen J WillerGeir BråthenIngunn BosnesJonas Bille NielsenLars G FritscheLaurent F ThomasLinda Margareth PedersenMaiken E GabrielsenMarianne Bakke JohnsenTore Wergeland MeisingsetWei ZhouPetroula ProitsiAngela K HodgesRichard James Butler DobsonLatha VelayudhanKarl HeilbronAdam Autonnull nullJulia M SealockLea K DavisNancy L PedersenChandra A ReynoldsIda K KarlssonSigurður H MagnussonHreinn StefánssonSteinunn ThordardottirPalmi V JonssonJon SnaedalAnna ZettergrenIngmar SkoogSilke KernMargda WaernHenrik ZetterbergKaj BlennowEystein StordalKristian HveemJohn-Anker ZwartLavinia AthanasiuPer SelnesIngvild SaltvedtSigrid B SandoIngun UlsteinSrdjan DjurovicTormod FladbyDag AarslandGeir SelbaekStephan RipkeKári StefánssonOle Andreas AndreassenDanielle PosthumaPublished in: Nature genetics (2021)
Late-onset Alzheimer's disease is a prevalent age-related polygenic disease that accounts for 50-70% of dementia cases. Currently, only a fraction of the genetic variants underlying Alzheimer's disease have been identified. Here we show that increased sample sizes allowed identification of seven previously unidentified genetic loci contributing to Alzheimer's disease. This study highlights microglia, immune cells and protein catabolism as relevant to late-onset Alzheimer's disease, while identifying and prioritizing previously unidentified genes of potential interest. We anticipate that these results can be included in larger meta-analyses of Alzheimer's disease to identify further genetic variants that contribute to Alzheimer's pathology.
Keyphrases